Minimally interrupted novel oral anticoagulant versus uninterrupted vitamin K antagonist during atrial fibrillation ablation

PURPOSE: The safety and efficacy of a minimally interrupted novel oral anticoagulant (NOAC) strategy at the time of atrial fibrillation (AF) ablation is uncertain. The purpose of this study was to compare rates of bleeding and thromboembolic events between minimally interrupted NOAC and uninterrupte...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Interv Card Electrophysiol
Asıl Yazarlar: De Heide, John, Vroegh, Christiaan J., Bhagwandien, Rohit E., Wijchers, Sip A., Szili-Torok, Tamas, Zijlstra, Felix, Lenzen, Mattie J., Yap, S. C.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer US 2018
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6292967/
https://ncbi.nlm.nih.gov/pubmed/30074120
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10840-018-0417-0
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller